BioMoti Company
BioMoti seeks to transform the treatment of cancer by targeted delivery of therapeutics to the intracellular space of cancer cells
Founded Date:
2006
Headquarters:
London, England, United Kingdom
Technology:
Small Molecules
Employee Number:
1-10
Industry:
PharmTech
Estimated Revenue:
Less than $1M
Number Of Exists:
N/A
Funding Status:
Seed
Investor Type:
N/A
Investment Stage:
N/A